~35 spots leftby Oct 2026

Surgical Techniques for C-Section

Recruiting in Palo Alto (17 mi)
JF
Overseen byJoshua F Nitsche, MD
Age: 18 - 65
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Wake Forest University Health Sciences
Must not be taking: Steroids
Disqualifiers: Non-English, Incarcerated, Connective tissue, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

Given the high numbers of cesarean deliveries being performed today, there has been interest in optimizing surgical techniques. Several recent reviews have summarized the evidence for various steps of cesarean delivery, but surprisingly in many cases there is little scientific evidence on which to base the choice of surgical technique.

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. However, if you are using systemic steroids, you would not be eligible to participate.

What data supports the effectiveness of the treatment absorbable subcuticular polyglycolic acid staples (INSORB) for C-section?

Research shows that Insorb absorbable staples can reduce the time it takes to close surgical incisions without compromising healing quality, as seen in studies involving abdominal and breast surgeries. Additionally, poliglecaprone-25 sutures, similar to those used in C-sections, have been shown to effectively close wounds with a low risk of complications.12345

Is the use of absorbable subcuticular staples and sutures safe for humans?

Research shows that absorbable subcuticular staples and sutures, like poliglecaprone 25 (Monocryl) and polyglycolic acid, are generally safe for use in humans. They cause minimal tissue reaction and are well-tolerated by the body, with low risk of inflammation at the site of use.12467

What makes the treatment with absorbable subcuticular polyglycolic acid staples (INSORB) and polyglecaprone suture (Monocryl) unique for C-section closure?

This treatment is unique because it uses absorbable staples and sutures that reduce closure time without compromising healing quality, offering a quicker and potentially more comfortable recovery compared to traditional non-absorbable sutures that require removal.12356

Research Team

JF

Joshua F Nitsche, MD

Principal Investigator

Wake Forest University Health Sciences

Eligibility Criteria

This trial is for individuals who have recently undergone a cesarean section (C-section) and are interested in the best method for wound closure to optimize healing and appearance. Specific eligibility criteria details were not provided.

Inclusion Criteria

Scheduled cesarean section
Any race
Any parity
See 2 more

Exclusion Criteria

Body Mass Index (BMI) >40
Non-English Speaking
Incarcerated
See 3 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo cesarean delivery with either Monocryl or INSORB absorbable staples for skin closure

6 weeks
In-hospital stay

Follow-up

Participants are monitored for scar cosmesis, pain, satisfaction, and wound complications

6 weeks
Digital photography and assessments

Treatment Details

Interventions

  • absorbable subcuticular polyglycolic acid staples (INSORB) (Procedure)
  • subcuticular, polyglecaprone suture (Monocryl) (Procedure)
Trial OverviewThe study is comparing two types of wound closure techniques after C-section: stitches with polyglecaprone suture (Monocryl) versus absorbable staples made of polyglycolic acid (INSORB). The goal is to determine which provides better cosmetic outcomes.
Participant Groups
2Treatment groups
Active Control
Group I: subcuticular absorbable polyglecaprone suture (Monocryl)Active Control1 Intervention
Monocryl absorbable staples are used for skin closure
Group II: subcuticular absorbable polyglycolic acid (INSORB) staplesActive Control1 Intervention
Insorb absorbable staples are used for skin closure

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wake Forest University Health Sciences

Lead Sponsor

Trials
1,432
Recruited
2,506,000+
Dr. L. Ebony Boulware profile image

Dr. L. Ebony Boulware

Wake Forest University Health Sciences

Chief Medical Officer since 2022

MD from Duke University School of Medicine, MPH from Johns Hopkins Bloomberg School of Public Health

Dr. Julie Ann Freischlag profile image

Dr. Julie Ann Freischlag

Wake Forest University Health Sciences

Chief Executive Officer since 2020

BS from University of Illinois, MD from Rush University

Findings from Research

Using Insorb absorbable staples for closing surgical incisions in procedures like mammaplasty and abdominoplasty significantly reduces closure time, being approximately 7 times faster than absorbable sutures.
Despite the faster closure time with staples, there were no significant differences in scar quality, pruritus, or pain between the two methods, indicating that staples are a safe and effective alternative for incision closure.
Placement of Absorbable Dermal Staples in Mammaplasty and Abdominoplasty: A 12-Month Prospective Study of 60 Patients.Bron, T., Zakine, G.[2016]
A study involving 124 women undergoing cesarean delivery found that both Monoglyde® and Monocryl® poliglecaprone-25 sutures had similar outcomes regarding wound complications, such as surgical site infections and wound dehiscence, within the first 30 days postpartum.
The research demonstrated that there were no significant differences in secondary outcomes, including pain levels, suture handling, and patient satisfaction, indicating that both sutures are equally effective and safe for use in skin closure after cesarean sections.
Clinical Equivalence of Monoglyde® and Monocryl® Absorbable Poliglecaprone-25 Sutures: A Single-Blind, Randomized Study.Sailakshmi, M., Misra, S., Hs, S., et al.[2023]
In a study comparing two suture techniques on 100 skin incisions, the absorbable polyglycolic acid (Dexon) sutures resulted in less inflammation and no increase in hypertrophic scar formation compared to the standard polyamid (Supramid) interrupted sutures.
While Dexon sutures produced broader scars, they offered slightly better cosmetic results and eliminated the need for suture removal, making them a recommended option for skin closure in children.
Polyglycolic acid, Dexon subcuticular suture in paediatric orthopaedic surgery.Fasting, OJ., Bjerkreim, I.[2007]

References

Placement of Absorbable Dermal Staples in Mammaplasty and Abdominoplasty: A 12-Month Prospective Study of 60 Patients. [2016]
Clinical Equivalence of Monoglyde® and Monocryl® Absorbable Poliglecaprone-25 Sutures: A Single-Blind, Randomized Study. [2023]
Polyglycolic acid, Dexon subcuticular suture in paediatric orthopaedic surgery. [2007]
Knotting abilities of a new absorbable monofilament suture: poliglecaprone 25 (Monocryl). [2008]
Reduction of skin closure time without loss of healing quality: a multicenter prospective study in 100 patients comparing the use of Insorb absorbable staples with absorbable thread for dermal suture. [2013]
[Experimental and clinical studies on the use of a new suture material: polyglycolic acid]. [2011]
Comparative study on biocompatibility and absorption times of three absorbable monofilament suture materials (Polydioxanone, Poliglecaprone 25, Glycomer 631). [2012]